Biophotonics - Global Strategic Business Report

BIOPHOTONICS

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Medical Therapeutics
Medical Diagnostics
Others
Non-Medical

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
Prelude
Expanding Application Base as the Major Growth Driver
Current and Future Analysis
Competitive Landscape
Expanding Applications Attract New Players

2. MARKET TRENDS, ISSUES AND DRIVERS
Optical In-Vitro Diagnostics
The Largest Market Segment for Biophotonics
Increasing Penetration of Diabetes Mellitus
Offers Opportunities for Biophotonics
Global Diabetic Statistics
Opportunity Indicators
Table 1: Worldwide Prevalence of Diabetes Mellitus by Region (2014 & 2035P) (includes corresponding Graph/Chart)
Table 2: Ten Countries with the Highest DM Cases (2014) (includes corresponding Graph/Chart)
Endoscopy
A Market with Immense Scope
Ophthalmology and Dermatology Major Application Segments for Medical Lasers
Food Diagnostics
An Emerging Niche
Drug Discovery & Development
A Potential Application Segment for Biophotonics
Opportunities Galore for Biophotonic Technologies in Infection Control
High-end Biophotonics to Find Major Application in Neurosciences
Coherent Develops Genetically Encoded Ultrafast Fiber Laser for Application in Neuroscience
Improving Healthcare Expenditure to Drive Demand for Biophotonics
Table 3: Per-Capita Healthcare Expenditure in Select Regions (2014) (includes corresponding Graph/Chart)
Table 4: Healthcare Spending as a Percentage of GDP by Geographic Region (2015E) (includes corresponding Graph/Chart)
Ageing Population to Spruce Up Biophotonics Development
Demographic Statistics
Opportunity Indicators for Biophotonics Market:
Table 5: Global Population Statistics for the 65+ Age Group (2013) (includes corresponding Graph/Chart)
Table 6: Elderly Population (60+ Years) as a Percentage of the Total Population (2012 & 2050) (includes corresponding Graph/Chart)
Growing Prominence of Biophotonics in Cancer Detection
Cancer Incidence and Mortality Statistics
A Perspective of Market Potential
Table 7: Worldwide Incidence of Cancer (2012, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)
Table 8: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Table 9: Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 10: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & Caribbean, and Africa (includes corresponding Graph/Chart)
Table 11: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal and Liver Cancers (includes corresponding Graph/Chart)
Table 12: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus and Liver Cancers (includes corresponding Graph/Chart)
Cancer Prone Sites based on Age
Biophotonics-based Tests for Detecting Coronary Artery Diseases
Photonics-based Breath Analysis Gaining Traction
OMI to Revolutionize Methodologies for Diagnosing and Treating Diseases
Advancements in Optical Filter Technology to Revolutionize Wearable Electronics and PoC Diagnostics
Diagnostic & Therapeutic Applications of Biophotonics Attract R&D Funding
Private Foundations Come Forth to Invest in Biophotonics
No
Table Technology Innovations and Research Advancements in the Biophotonics Field
CBSS Develops Optical Microscopes for Disease Diagnosis & Treatment
University of Adelaide Focuses on Biophotonics for Research on Life Processes
Texas A&M University’s Invests in Multidisciplinary Biophotonics Research
NSF Grants Funds for Biomolecule Imaging using X-Ray Lasers
Photoplethysmography-Based DistancePPG to Aid in Monitoring Vital Signs
Permanent Fluorescent Label Helps Researchers in Studying Neural Activities
Researchers Develop Glucolight System for Non- Invasive Measurement of Blood Glucose Levels
Researchers Develop SCAPE Microscopy for 3D Imaging of Moving Samples
Japanese Researchers Develop Nanolaser to Identify Specific Biomolecules
Novel Phototherapy and Imaging Technique to Target and Destroy Cancer Cells
Researchers Develop Multicolor RGB Marking to Color-Code Neural Cells
EHT Model Holds Potential to Enable Tailored Optogenetics Proteins
Researchers at University of Buffalo to Develop Endoscope for High-Contrast Imaging of Cancer Tumors
Photoacoustic Imaging to Provide Effective Solution to Detect Cervical Cancer
Photoacoustic Device Allows Researchers to Diagnose Melanoma
LIAFS/DRS Technique to Improve Melanoma Diagnosis
Raman Spectroscopy Enables Faster, Accurate Diagnosis of Cancer
Light-based Approaches to Help Researchers in Studying Brain Function
Researchers Develop Lens-Free On-Chip Microscope to Produce High-Resolution Images
Fluorescent Dye-Coated Nanoparticles to Target Disease Causing Genes
UK Sets Up Quantum Technology Research Hubs to Explore Light Detectors
Stimulation of Receptors Using Light to Relax Blood Vessels
MIR Laser Produces X-Ray Pulses with High Flux
Phosphorescent Bandage to Monitor Oxygen Concentration for Wound Assessment
Sophisticated Microscopy Technique to Enable Single- Cell, High-Resolution Imaging of Entire Body
Violet-Blue Light Controlled Medicine to Provide Effective Treatment Option for Diabetic Patients
Magnetic Nanoparticles to Assist Researchers in Bio-Imaging Applications
UV Light with Manual Cleaning to Prevent Spread of Superbugs in Hospitals
Researchers Explore Use of OCT to Understand Acne Lesion
Novel Fluorescent Probes to Enable Detection of Lysosomal pH Levels
Researchers Develop New Range of Fluorescence Markers for Imaging Applications
Researchers Develop Optogenetic Technique to Map Neural Networks
IR Quantum Cascade Laser to Provide Convenient Solution to Monitor Blood Glucose Levels
Wearable Optical Device to Enable Timely Identification of Diabetes Complication
New Fluorescence-enhanced Test to Identify People at Higher Risk of Developing Diabetes
Fluorescence Imaging Techniques to Detect Alzheimer’s Indicators in Eye
Adaptive Optics Allows Physicians to Detect Early Signs of Diabetes Eye Damage
New Technique Uses Femtosecond Lasers for Controlled, Precise Drug Delivery

3. AN INTRODUCTION TO BIOPHOTONICS
Definition
Select Light Sources for Biophotonics
Gas Lasers
Diode Lasers
Applications
Biophotonics in Diagnostics
Biophotonics in Therapeutics
Biophotonics in Biotechnology
Other Emerging Applications of Biophotonics
Optical Sectional Microscopy
Photon Limited Microscopy
Fluorescence Microscopy
Time-Resolved Fluorescence Spectroscopy
Fluorescence Lifetime Imaging Microscopy
Caged Bioactive Probes
End-Use Sectors

4. PRODUCT INNOVATIONS/INTRODUCTIONS
Taiwan Biophotonic Unveils DOE Reflective Sensor for Fingerless Wrist-Worn Pulse Oximeters
Lumenis Introduces New ResurFX System for Skin Resurfacing Treatment
Olympus Introduces Two New Configurations to its FLUOVIEW FVMPE-RS Series
KLOX Technologies Obtains CE Mark for LumiHeal™ Medical Device
AdvanDx Obtains FDA Approval for mecA XpressFISH™
BIOLASE Unveils EPIC™ X Diode Laser
BioTek Unveils New Cytation Imaging Multi-Mode Reader
Lumenis to Launch LightSheer® DESIRE™ and LightSheer® INFINITY™ in Europe
Lumenis Unveils New Q-Switched Nd:YAG Module for the M22™ Platform
Lumenis Launches LightSheer® DESIRE™ and LightSheer® INFINITY™ Laser Hair Removal Systems
Picoquant Unveils Picosecond Pulsed Diode Laser Head
Biophotas Launches Celluma™ ELITE for Aesthetic Physician Market
AdvanDx Introduces Candida QuickFISH Rapid Diagnostic
AdvanDx Introduces Gram-Negative QuickFISH BC
AdvanDx Launches Enterococcus QuickFISH BC
BIOLASE Receives License to Sell EPIC 10 Soft-Tissue Diode Laser in Canada
Lumenis to Introduce ResurFX™

5. RECENT INDUSTRY ACTIVITY
Newport Corporation to Acquire FEMTOLASERS
Hamilton Thorne Takes Over CRi’s Reproductive Imaging Product Range
The University of St Andrews Enters into Partnership with M Squared Lasers
Edmund Optics Enters into Partnership with Luxexcel Group
First Light Imaging Obtains EC Grant for Working on IR Camera
Excelitas Technologies Collaborates with Kinetic River Corp to Design Flow Cytometer Prototype
Horiba Acquires Photon Technology International
Newport Takes Over V-Gen
Zecotek Signs Joint Collaboration Agreement with Hamamatsu Photonics
Bausch + Lomb to Take Over Technolas Perfect Vision GmbH

6. FOCUS ON SELECT GLOBAL PLAYERS
AdvanDx, Inc. (US)
Affymetrix, Inc. (US)
Andor Technology plc (Ireland)
Becton, Dickinson and Company (US)
BioTek Instruments, Inc. (US)
BIOLASE, Inc. (US)
Carl Zeiss MicroImaging GmbH (Germany)
CEA-Leti (France)
Endra, Inc. (US)
Epi-Light Limited (Ireland)
FEI Company (US)
Glenbrook Technologies, Inc. (US)
Hamamatsu Photonics K.K. (Japan)
HORIBA, Ltd. (Japan)
Lumenis Ltd. (Israel)
Newport Corporation (US)
Ocean Optics, Inc. (US)
Olympus America, Inc. (US)
PerkinElmer, Inc. (US)
Photocure ASA (Norway)
PicoQuant GmbH (Germany)
Solta Medical, Inc. (US)
Zecotek Photonics, Inc. (Singapore)
Zenalux Biomedical, Inc. (US)

7. GLOBAL MARKET PERSPECTIVE
Table 13: World Recent Past, Current and Future Analysis for Biophotonics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 14: World Historic Review for Biophotonics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 15: World 14-Year Perspective for Biophotonics by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Biophotonics Market Analytics by End-Use Sector
Table 16: World Recent Past, Current and Future Analysis for Medical Applications of Biophotonics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 17: World Historic Review for Medical Applications of Biophotonics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 18: World 14-Year Perspective for Medical Applications of Biophotonics by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 19: World Recent Past, Current and Future Analysis for Biophotonics in Medical Therapeutics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 20: World Historic Review for Biophotonics in Medical Therapeutics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 21: World 14-Year Perspective for Biophotonics in Medical Therapeutics by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 22: World Recent Past, Current and Future Analysis for Biophotonics in Medical Diagnostics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 23: World Historic Review for Biophotonics in Medical Diagnostics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 24: World 14-Year Perspective for Biophotonics in Medical Diagnostics by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 25: World Recent Past, Current and Future Analysis for Other Medical Biophotonics Applications by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 26: World Historic Review for Other Medical Biophotonics Applications by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 27: World 14-Year Perspective for Other Medical Biophotonics Applications by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 28: World Recent Past, Current and Future Analysis for Non-Medical Applications of Biophotonics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 29: World Historic Review for Non-Medical Applications of Biophotonics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 30: World 14-Year Perspective for Non-Medical Applications of Biophotonics by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Outlook
Biophotonics for Medical Devices
Life Science Research Tools Benefit from Photonics Technology
Rapidly Aging Demographics: A Major Driving Factor
Table 31: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart)
Rising Incidences of Chronic Diseases Enhance Demand for Biophotonics
Cancer Prevalence Statistics in the US
Growth Opportunities for Biophotonics
Table 32: New Cancer Cases in US by State: 2014 (includes corresponding Graph/Chart)
Table 33: Number of Deaths Related to Major Types of Cancer in US by State: 2014 (includes corresponding Graph/Chart)
Table 34: New Cancer Cases in the US by Gender and Affected Site: 2014 (includes corresponding Graph/Chart)
Table 35: US Cancer Incidence for All Body Sites by Gender & Age Group (2013): New Cancer Cases for Males & Females for the Age groups Under 45 years; 45 years and Above; Under 65 years; and 65 years and Above (includes corresponding Graph/Chart)
Prevalence of Diabetes Mellitus in North America
Table 36: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in North America and Caribbean (2014): Breakdown by Country/ Territory (in 000 People & %)
Product Launches
Strategic Corporate Developments
Select Players
B.Market Analytics
Table 37: US Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 38: US Historic Review for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 39: US 14-Year Perspective for Biophotonics by End-Use Sector
Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Outlook
Rising Incidence of Cancer
A Business Case for Biophotonics
Table 40: New Cancer Cases in Canada by Gender and Affected Site: 2014 (includes corresponding Graph/Chart)
Table 41: New Cancer Cases in Canada by Province: 2014 (includes corresponding Graph/Chart)
Table 42: New Cancer Cases in Canada by Age Group: 2014 (includes corresponding Graph/Chart)
Table 43: Cancer Related Deaths in Canada by Gender and Affected Site: 2014 (includes corresponding Graph/Chart)
Table 44: Cancer Related Deaths in Canada by Province: 2014 (includes corresponding Graph/Chart)
Table 45: Cancer Related Deaths in Canada by Age Group: 2014 (includes corresponding Graph/Chart)
Increasing Penetration of DM
An Opportunity for Biophotonics
Table 46: Prevalence of Diabetes Mellitus in Canada: 2014
Product Launch
B.Market Analytics
Table 47: Canadian Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 48: Canadian Historic Review for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 49: Canadian 14-Year Perspective for Biophotonics by End-Use Sector
Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Outlook
Rising Cancer and Diabetes Cases Provide Growth Opportunity
Table 50: Cancer Related Deaths by Age Groups: 2013 (includes corresponding Graph/Chart)
Table 51: Prevalence of Diabetes Mellitus in Japan (2014)
Select Players
B.Market Analytics
Table 52: Japanese Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 53: Japanese Historic Review for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 54: Japanese 14-Year Perspective for Biophotonics by End-Use Sector
Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Market Overview
Aging Population & Rising Incidence of Chronic Diseases to Drive Growth
Table 55: Population Breakup by Age Group for Select European Countries: 2012 (as a Percentage of Total Population) (includes corresponding Graph/Chart)
Cancer and Diabetes Mellitus in Europe: Key Statistics
Table 56: European Predicted Cancer Deaths in 2014: Number of Deaths by Gender and Major Cancer Type (includes corresponding Graph/Chart)
Table 57: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in Europe by Country/Territory (2014) (In 000 People & %) (includes corresponding Graph/Chart)
Product Launch
B.Market Analytics
Table 58: European Recent Past, Current and Future Analysis for Biophotonics by Geographic Region
France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 59: European Historic Review for Biophotonics by Geographic Region
France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 60: European 14-Year Perspective for Biophotonics by Geographic Region
Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 61: European Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 62: European Historic Review for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 63: European 14-Year Perspective for Biophotonics by End-Use Sector
Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4a. FRANCE
A.Market Analysis
Outlook
Corporate Development
CEA-LETI
A Key Player
B.Market Analytics
Table 64: French Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 65: French Historic Review for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 66: French 14-Year Perspective for Biophotonics by End-Use Sector
Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4b. GERMANY
A.Market Analysis
Outlook
Strategic Corporate Developments
Select Players
B.Market Analytics
Table 67: German Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 68: German Historic Review for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 69: German 14-Year Perspective for Biophotonics by End-Use Sector
Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4c. ITALY
Market Analysis
Table 70: Italian Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 71: Italian Historic Review for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 72: Italian 14-Year Perspective for Biophotonics by End-Use Sector
Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
Market Analysis
Table 73: UK Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 74: UK Historic Review for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 75: UK 14-Year Perspective for Biophotonics by End-Use Sector
Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4e. SPAIN
A.Market Analysis
Outlook
Select Players
B.Market Analytics
Table 76: Spanish Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 77: Spanish Historic Review for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 78: Spanish 14-Year Perspective for Biophotonics by End-Use Sector
Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4f. RUSSIA
A.Market Analysis
Outlook
INJECT ENTERPRISE
A Major Player
B.Market Analytics
Table 79: Russian Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 80: Russian Historic Review for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 81: Russian 14-Year Perspective for Biophotonics by End-Use Sector
Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4g. REST OF EUROPE
A.Market Analysis
Outlook
Key Players
B.Market Analytics
Table 82: Rest of Europe Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 83: Rest of Europe Historic Review for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 84: Rest of Europe 14-Year Perspective for Biophotonics by End-Use Sector
Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A.Market Analysis
Outlook
Increasing Prevalence of Diabetes to Drive Biophotonics Market
Diabetes Statistics in Asia-Pacific
Opportunity Indicators
Table 85: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in Southeast Asia (2014): Breakdown by Country/ Territory (in 000 People & %) (includes corresponding Graph/Chart)
Table 86: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in Western Asia by Country/Territory (2014) (In 000s & %)
Table 87: Incidence of Type 1 Diabetes in Children by Select Countries in Western Pacific (2012) (includes corresponding Graph/Chart)
China
Strategic Corporate Developments
Zecotek Photonics, Inc.
A Major Player
B.Market Analytics
Table 88: Asia-Pacific Recent Past, Current and Future Analysis for Biophotonics by Geographic Region
China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 89: Asia-Pacific Historic Review for Biophotonics by Geographic Region
China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 90: Asia-Pacific 14-Year Perspective for Biophotonics by Geographic Region
Percentage Breakdown of Revenues for China, India, and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 91: Asia-Pacific Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 92: Asia-Pacific Historic Review for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 93: Asia-Pacific 14-Year Perspective for Biophotonics by End-Use Sector
Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA
A.Market Analysis
Outlook
Rising Incidence of Diabetes in Latin America
Opportunity Indicator
Table 94: Prevalence of Diabetes Mellitus in South & Central America (2013 & 2035): Breakdown by Country and Age Group (In 000 People & %) (includes corresponding Graph/Chart)
B.Market Analytics
Table 95: Latin America Recent Past, Current and Future Analysis for Biophotonics by Geographic Region
Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 96: Latin America Historic Review for Biophotonics by Geographic Region
Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 97: Latin America 14-Year Perspective for Biophotonics by Geographic Region
Percentage Breakdown of Revenues for Brazil, and Rest of Latin America Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 98: Latin America Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 99: Latin America Historic Review for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 100: Latin America 14-Year Perspective for Biophotonics by End-Use Sector
Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD
A.Market Analysis
Outlook
Increasing Incidence of Chronic Conditions: Opportunity for Biophotonics
Diabetes Prevalence Statistics
Table 101: Prevalence of Diabetes Mellitus among 20-79 Yrs Age Group in Africa (2014): Breakdown by Country/Territory (in 000 People & %) (includes corresponding Graph/Chart)
Table 102: Prevalence of Diabetes Mellitus in Middle East & North Africa (2014): Breakdown by Country/Territory and Age Group (in 000 People & %) (includes corresponding Graph/Chart)
Table 103: African Population and Diabetes Prevalence Statistics (2013)
Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart)
Table 104: Middle East and North African Population and Diabetes Prevalence Statistics (2013 Estimates)
Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart)
Product Launches
Lumenis ltd. (Israel)
A Key Player
B.Market Analytics
Table 105: Rest of World Recent Past, Current and Future Analysis for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 106: Rest of World Historic Review for Biophotonics by End-Use Sector
Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 107: Rest of World 14-Year Perspective for Biophotonics by End-Use Sector
Percentage Breakdown of Revenues for Medical (Therapeutics, Diagnostics, and Others) and Non-Medical Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 85 (including Divisions/Subsidiaries 88)
The United States (45)
Canada (5)
Japan (4)
Europe (30)

• France (3)
• Germany (9)
• The United Kingdom (3)
• Spain (2)
• Rest of Europe (13)

Asia-Pacific (Excluding Japan) (2)
Middle East (2)